A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
収録刊行物
-
- International Journal of Hematology
-
International Journal of Hematology 89 (5), 679-688, 2009-05-19
Springer Science and Business Media LLC